How do I administer the Patient Health Questionnaire‑9 (PHQ‑9)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

How to Administer the PHQ-9

The PHQ-9 is a 9-item self-report questionnaire that patients complete themselves, assessing depressive symptoms over the past 2 weeks, with each item scored from 0 ("not at all") to 3 ("nearly every day"), yielding a total score of 0-27. 1

Administration Method

Step 1: Use a Phased Screening Approach

  • Begin with the PHQ-2 (the first two items only) as an initial screen for all patients 1:

    • Item 1: "Little interest or pleasure in doing things" (anhedonia)
    • Item 2: "Feeling down, depressed or helpless" (depressed mood)
  • If the patient scores 0 or 1 on the PHQ-2, no further screening is needed 1

  • If the patient scores 2 or 3 on the PHQ-2 (endorsing either symptom as occurring "more than half the days" or "nearly every day"), proceed to administer the full PHQ-9 1

  • This phased approach means only 25-30% of patients will need to complete all 9 items 1

Step 2: Complete the Full PHQ-9

The remaining 7 items assess 1:

  • Sleep problems
  • Low energy
  • Appetite changes
  • Low self-view
  • Concentration difficulties
  • Motor retardation or agitation
  • Thoughts of self-harm

Administration Formats

The PHQ-9 can be administered in multiple ways 2, 3:

  • Self-administered paper form - most common method 1
  • Clinician-administered interview - takes 3-15 minutes, useful for low-literacy populations 2
  • Touch screen computer/electronic format - feasible with 97% completion rates and approximately 2-minute completion time 3
  • Embedded in electronic health records (EHR) - allows automatic scoring and clinical alerts 4

Scoring and Interpretation

Score Ranges

Use a cutoff score of 8 (not the traditional 10) for cancer patients and similar populations 1:

  • Score 1-7: None/mild symptomatology - no or minimal symptoms of depression 1
  • Score 8-14: Moderate symptomatology - subthreshold depressive symptoms with mild to moderate functional impairment 1
  • Score 15-19: Moderate to severe symptomatology - most depressive symptoms present with moderate functional interference 1
  • Score 20-27: Severe symptomatology - symptoms interfere markedly with functioning 1

The lower cutoff of 8 is supported by validation studies in cancer outpatients and meta-analyses 1

Critical Safety Considerations

Suicidality Assessment

Item 9 specifically assesses thoughts of self-harm: "Thoughts that you would be better off dead or hurting yourself in some way" 1

  • Any endorsement of suicidality requires immediate evaluation of frequency and specificity of thoughts 1
  • If patient is at risk of harm to self or others: immediate referral for emergency evaluation by a licensed mental health professional, facilitate safe environment, one-to-one observation, and initiate harm-reduction interventions 1

Do not omit item 9 - while some clinicians choose to administer only 8 items, this artificially lowers the score, risks missing patients with more severe symptoms, and weakens predictive validity 1

When to Screen

Screen at multiple time points 1:

  • Initial diagnosis/start of treatment
  • Regular intervals during treatment
  • 3,6, and 12 months after treatment
  • At diagnosis of recurrence or progression
  • When approaching death
  • During times of personal transition or family crisis

Important Implementation Considerations

Training Requirements

  • Rater training requires approximately 30 minutes of instruction for physicians and medical students 2
  • Quality monitoring is essential - in routine care settings, clinician-administered PHQ-9 may have high specificity (90-99%) but low sensitivity (23-68%) compared to carefully supervised administration 5
  • Ongoing training, support, supervision, and monitoring are necessary to ensure quality administration 5

Cultural and Linguistic Adaptations

  • No major modifications are typically needed for cultural differences in Spanish-speaking populations 2
  • Be aware of potential item functioning differences across languages and cultures, particularly for items assessing appetite, sleep, and psychomotor changes 6
  • Use culturally sensitive assessments when possible 1

Special Populations

  • Tailor assessment for those with learning disabilities or cognitive impairments 1
  • Be aware of difficulty detecting depression in older adults 1
  • The PHQ-9 has been validated in low-literacy populations when administered by interview 2

Follow-Up Actions Based on Scores

For scores 8-14 (moderate): Seek consultation with psychology or psychiatry for determination of diagnosis 1

For scores 15-27 (moderate to severe/severe): Referral to psychology and/or psychiatry for diagnosis and treatment 1

Before treating depression symptoms: First address medical causes such as unrelieved pain, fatigue, or delirium from infection or electrolyte imbalance 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.